As of 2026-04-04, the Intrinsic Value of Rici Healthcare Holdings Ltd (1526.HK) is 4.43 HKD. This 1526.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.83 HKD, the upside of Rici Healthcare Holdings Ltd is 433.80%.
The range of the Intrinsic Value is 2.96 - 7.91 HKD
Based on its market price of 0.83 HKD and our intrinsic valuation, Rici Healthcare Holdings Ltd (1526.HK) is undervalued by 433.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.96 - 7.91 | 4.43 | 433.8% |
| DCF (Growth 10y) | 3.83 - 9.91 | 5.64 | 579.0% |
| DCF (EBITDA 5y) | 3.51 - 5.57 | 4.45 | 435.7% |
| DCF (EBITDA 10y) | 4.19 - 7.16 | 5.47 | 559.0% |
| Fair Value | 4.78 - 4.78 | 4.78 | 475.86% |
| P/E | 2.44 - 4.09 | 3.27 | 293.9% |
| EV/EBITDA | 1.64 - 3.07 | 2.38 | 187.3% |
| EPV | 3.31 - 6.89 | 5.10 | 514.4% |
| DDM - Stable | 0.78 - 2.64 | 1.71 | 105.9% |
| DDM - Multi | 1.03 - 3.18 | 1.61 | 94.0% |
| Market Cap (mil) | 1,319.97 |
| Beta | 0.54 |
| Outstanding shares (mil) | 1,590.32 |
| Enterprise Value (mil) | 2,699.06 |
| Market risk premium | 5.98% |
| Cost of Equity | 12.35% |
| Cost of Debt | 4.70% |
| WACC | 6.56% |